-
-
Healthcare in general and cardiovascular medicine in particular must declare all-out war against heart failure.
-
In an opening plenary session at this year's conference of the Heart Failure Society of America (St. Paul, Minnesota), Gale Pearson, of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, laid out what she called a "roadmap" and a "blueprint" developed by the NHLBI to provide "global leadership" and a "strategic planning process" as an "optimal heart failure research catalyst."
-
How do you do a randomized controlled trial (RCT) when the product you are testing seems to be such a great potential advancement that you can't talk patients into enrolling into control groups?
-
A new meta-analysis published last month in The Lancet is being touted as easing concerns about drug-eluting stents (DES), but it may not do all that much to provide great confidence - or reverse the slump - in this device sector.
-
Linda Davrath has been named head of clinical research and clinical application for BSP Medical (Tel Aviv, Israel).
-
Luna Innovations (Roanoke, Virginia) reported that it has entered a joint marketing alliance with Terumo Cardiovascular Systems (Terumo CVS). Luna and Terumo CVS will market Luna's EDAC (Emboli Detection and Classification) Quantifier for clinical use in the U.S.
-
A 27-year-old former college football player came in for an elective procedure to relieve hip pain. According to media reports, he hoped the surgery would clear a path for him to audition for a professional football team.
-
Many health care providers are formally adopting policies that state they will not bill patients or insurers for the worst type of mistakes known as "never events" because they should never happen. One example is intraoperative or immediately postoperative death in an ASA Class I patient.
-
Surgeons have long been reluctant to use blunt suture needles, but new messages from the American College of Surgeons (ACS), the Occupational Safety and Health Administration (OSHA), and the National Institute for Occupational Safety and Health (NIOSH) may get their attention. Those organizations are actively promoting the use of blunt suture needles.
